-+ 0.00%
-+ 0.00%
-+ 0.00%

TISSUE DYNAMICS AND GALMED PHARMACEUTICALS TO DEVELOP HUMAN-CENTERED CHRONIC CARDIAC FIBROSIS PLATFORM TO ADVANCE ARAMCHOL-BASED THERAPEUTICS

Reuters·05/06/2026 11:31:25

Please log in to view news